Navigation Links
The American Society of Hematology Elects New Leadership
Date:11/3/2009

WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology, the world's largest professional society of blood specialists, welcomes five new officers to its Executive Committee, the governing body of the organization. The officers will begin serving their terms in January 2010.

Armand Keating, MD, will serve a one-year term as vice-president, followed by successive terms as president-elect and president. New councillors Marilyn J. Telen, MD, and Kenneth C. Anderson, MD, will serve four-year terms, and Mohandas Narla, DSc, will serve as councillor for a one-year term. These individuals are well-respected hematologists and active members of the Society.

Dr. Keating is Professor of Medicine and Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and Director, Cell Therapy Program, Princess Margaret Hospital, Toronto. His clinical and research interests focus on anti-cancer cell therapy, blood and marrow transplantation, leukemia, lymphoma, and cell-based tissue regeneration. He has conducted laboratory, translational, and clinical research in cell therapy, normal and leukemic hematopoiesis, and the biology and clinical application of mesenchymal stromal cells.

Dr. Telen, Wellcome Professor of Medicine and Chief, Division of Hematology, Duke University Medical Center, is recognized as an expert in the biochemistry and molecular genetics of blood group antigens and the pathophysiological mechanisms of vaso-occlusion in sickle cell disease. She is the director of the Duke Comprehensive Sickle Cell Center.

Dr. Anderson, Kraft Family Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute (DFCI), is Chief of the Division of Hematologic Neoplasia, Director of the Lipper Myeloma Center and Lebow Institute for Myeloma Therapeutics, and Vice Chair of the Joint Program in Transfusion Medicine at DFCI. His area of research is novel biologically based therapies for multiple myeloma.

Dr. Narla, Vice President for Research, New York Blood Center, is the Director of the Lindsley F. Kimball Research Institute and heads the Laboratory of Red Cell Physiology at New York Blood Center. His primary research focus is the study of the structural organization of blood cell membranes in health and disease and on regulation of blood cell production.

Reporters who wish to arrange an interview may contact Patrick C. Irelan, ASH Communications Assistant, at 202-776-0544 or pirelan@hematology.org.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

SOURCE American Society of Hematology


'/>"/>
SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... International Water Advocate ... Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on ... focus from a once-every-four-years series of events to a personal, daily Health Olympics. ...
(Date:9/25/2017)... ... , ... Bobbie Horowitz was hardly able to walk without excruciating pain in ... and theater producer, Horowitz would manage to get to rehearsals on time, but wasn’t ... so she had to take a cab everywhere. , It wasn’t until she ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... technology-enabled services supporting clinical research, today announces that 30 of its domain ... the drug development lifecycle at upcoming industry conferences and webinars. Drawing on ...
(Date:9/25/2017)... ... September 25, 2017 , ... Physician Partners of America announces that Chad Gorman, ... as an interventional pain management specialist. , Dr. Gorman is a board-certified physician ... private practice In Brooksville, Fla. His orthopedic background puts him in a unique position ...
(Date:9/25/2017)... New York (PRWEB) , ... September 25, 2017 ... ... Laser & Microsurgery Institute is excited to announce the next generation for LASIK ... Contoura is one of the most technologically advanced laser systems available in the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
Breaking Medicine Technology: